Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14171)
All Articles published online
|
Publishing Process of This Article
|
Nov 6, 2015 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Kim SY, Choi DJ, Chung JW. Antibiotic treatment for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i4/183.htm |
| Number | Citing Articles |
| 1 |
Mansour Amin, Ali Akbar Shayesteh, Amirarsalan Serajian, Hamed Goodarzi. Assessment of Metronidazole and Clarithromycin Resistance Among Helicobacter pylori Isolates of Ahvaz (Southwest of Iran) During 2015 - 2016 by Phenotypic and Molecular Methods. Jundishapur Journal of Microbiology 2019; (In Press) doi: 10.5812/jjm.80156
|
| 2 |
Sohaib Khan, Mohamed Sharaf, Ishfaq Ahmed, Tehsin Ullah Khan, Samah Shabana, Muhammad Arif, Syed Shabi Ul Hassan Kazmi, Chenguang Liu. Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori. Expert Review of Anti-infective Therapy 2022; 20(3): 407 doi: 10.1080/14787210.2022.1990041
|
| 3 |
Seokin Kang, Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Nayoung Kim, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics 2021; 10(2): 214 doi: 10.3390/antibiotics10020214
|
| 4 |
Elizabeth A. Marcus, George Sachs, David R. Scott. Eradication of Helicobacter pylori Infection. Current Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0509-x
|
| 5 |
Verena Friedrich, Markus Gerhard. Vaccination against Helicobacter pylori – An approach for cancer prevention?. Molecular Aspects of Medicine 2023; 92: 101183 doi: 10.1016/j.mam.2023.101183
|
| 6 |
Neha Sharda, Deepak Kumar, Raman Thakur, Anil K. Sharma, Shailja Sankhyan, Anil Kumar. Environmental Antibiotic Resistance: Recent Trends, Scope, and Relevance. Water, Air, & Soil Pollution 2023; 234(11) doi: 10.1007/s11270-023-06695-w
|
| 7 |
Y. Dasteh Goli, R. Moniri. Efficacy of probiotics as an adjuvant agent in eradication of Helicobacter pylori infection and associated side effects. Beneficial Microbes 2016; 7(4): 519 doi: 10.3920/BM2015.0130
|
| 8 |
Ali Chaudhry. Pharmacist guidelines and considerations for treating H. pylori. Journal of Analytical & Pharmaceutical Research 2018; 7(2) doi: 10.15406/japlr.2018.07.00222
|
| 9 |
Farnaz Fahimi, Mohammad Reza Tohidkia, Mehdi Fouladi, Reza Aghabeygi, Naser Samadi, Yadollah Omidi. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. BioImpacts 2017; 7(1): 59 doi: 10.15171/bi.2017.08
|
| 10 |
Taslima Zaman, Ahsanul Haq, Rahnuma Ahmad, Susmita Sinha, Kona Chowdhury, Sultana Parvin, Mostofa Imran, Zaman U Humayra, Santosh Kumar, Mainul Haque. The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh. Cureus 2024; doi: 10.7759/cureus.56283
|
| 11 |
Skander Hathroubi, Julia Zerebinski, Karen M. Ottemann, Nancy E. Freitag, Regine Hengge, Timothy Cover. Helicobacter pylori Biofilm Involves a Multigene Stress-Biased Response, Including a Structural Role for Flagella. mBio 2018; 9(5) doi: 10.1128/mBio.01973-18
|
| 12 |
Ryo Inose, Yuichi Muraki, Yoko Kamimoto, Yoshiki Kusama, Ryuji Koizumi, Daisuke Yamasaki, Masahiro Ishikane, Masaki Tanabe, Norio Ohmagari. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. Journal of Infection and Chemotherapy 2022; 28(2): 356 doi: 10.1016/j.jiac.2021.12.004
|
| 13 |
Ronak Nikbazm, Zahra Rahimi, Yousef Moradi, Meysam Alipour, Farzad Shidfar. The effect of cranberry supplementation on Helicobacter pylori eradication in H. pylori positive subjects: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition 2022; 128(6): 1090 doi: 10.1017/S0007114521004256
|
| 14 |
Marina R. Wylie, Ian H. Windham, Faith C. Blum, Hannah Wu, D. Scott Merrell. In vitro antibacterial activity of nimbolide against Helicobacter pylori. Journal of Ethnopharmacology 2022; 285: 114828 doi: 10.1016/j.jep.2021.114828
|
| 15 |
Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong. In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains. Gut and Liver 2017; 11(5): 648 doi: 10.5009/gnl16503
|
| 16 |
Van Huy Tran, Thi Mai Ngan Nguyen, Phan Tuong Quynh Le, Thi Huyen Thuong Nguyen, Thi Chau Loan Nguyen, Thi Minh Thi Ha. Current status of Helicobacter pylori resistance to clarithromycin and levofloxacin in Vietnam: Results from molecular analysis of gastric biopsy specimens. Journal of Global Antimicrobial Resistance 2024; 36: 76 doi: 10.1016/j.jgar.2023.12.026
|
| 17 |
Maria Pina Dore, Hong Lu, David Y Graham. Role of bismuth in improvingHelicobacter pylorieradication with triple therapy. Gut 2016; 65(5): 870 doi: 10.1136/gutjnl-2015-311019
|
| 18 |
Joyanta K. Modak, Yu C. Liu, Claudiu T. Supuran, Anna Roujeinikova. Structure–Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase. Journal of Medicinal Chemistry 2016; 59(24): 11098 doi: 10.1021/acs.jmedchem.6b01333
|
| 19 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 20 |
Michael G. Bruce, Dana Bruden, Deidra Newbrough, Debby A. Hurlburt, Thomas W. Hennessy, Julie M. Morris, Alisa L. Reasonover, Frank Sacco, Brian J. McMahon. The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated forHelicobacter pyloriinfection. GastroHep 2019; doi: 10.1002/ygh2.352
|
| 21 |
Muhammad Farhan Sarwar, Afnan Zahra, Mudassar Fareed Awan, Sajed Ali, Muhammad Shafiq, Khursheed Muzammil, Guadalupe Virginia Nevárez-Moorillón. Assessing the efficacy of cinnamon compounds against H. pylori through molecular docking, MD Simulations and ADMET analyses. PLOS ONE 2024; 19(3): e0299378 doi: 10.1371/journal.pone.0299378
|
| 22 |
Marius Zeeb, Tobias Kerrinnes, Luka Cicin-Sain, Carlos A. Guzman, Wolfram Puppe, Thomas F. Schulz, Annette Peters, Klaus Berger, Stefanie Castell, André Karch. Seropositivity for pathogens associated with chronic infections is a risk factor for all-cause mortality in the elderly: findings from the Memory and Morbidity in Augsburg Elderly (MEMO) Study. GeroScience 2020; 42(5): 1365 doi: 10.1007/s11357-020-00216-x
|
| 23 |
Meiliang Gong, Yingjie Han, Xuning Wang, Hongjin Tao, Fansen Meng, Baicun Hou, Benjamin B. Sun, Gangshi Wang. Effect of Temperature on Metronidazole Resistance in Helicobacter pylori. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.681911
|
| 24 |
Axel Haverich, Erin Colleen Boyle. Atherosclerosis Pathogenesis and Microvascular Dysfunction. 2019; : 9 doi: 10.1007/978-3-030-20245-3_2
|
| 25 |
Mengqiu Xiong, Hend Sadeq Mohammed Aljaberi, Nida Khalid Ansari, Yalan Sun, Sijie Yin, Lubanga Nasifu, Huiling Sun, Tao Xu, Yuqin Pan, Zhenlin Nie, Caidong Liu, Zhenyu Zhang, Zongdan Jiang, Shukui Wang, Bangshun He, Yuan Pin Hung.
Phenotype and genotype analysis for
Helicobacter pylori
antibiotic resistance in outpatients: a retrospective study
. Microbiology Spectrum 2023; 11(5) doi: 10.1128/spectrum.00550-23
|
| 26 |
Romelia Pop, Alexandru-Flaviu Tăbăran, Andrei Paul Ungur, Andrada Negoescu, Cornel Cătoi. Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver Nanoparticles. Pharmaceutics 2022; 14(7): 1463 doi: 10.3390/pharmaceutics14071463
|
| 27 |
Amin Talebi Bezmin Abadi. Vaccine against <i>Helicobacter pylori</i>: Inevitable approach. World Journal of Gastroenterology 2016; 22(11): 3150-3157 doi: 10.3748/wjg.v22.i11.3150
|
| 28 |
Abdullah Shah, Omer Usman, Tafseer Zahra, Sandipkumar S Chaudhari, Gopi Sairam Reddy Mulaka, Rumaisa Masood, Saima Batool, Faraz Saleem. Efficacy and Safety of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors as Helicobacter pylori Eradication Therapy: A Meta-Analysis of Randomized Clinical Trials. Cureus 2023; doi: 10.7759/cureus.48465
|
| 29 |
Federico Antoniciello, Davide Roncarati, Annamaria Zannoni, Elena Chiti, Vincenzo Scarlato, Federica Chiappori. Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.887564
|
| 30 |
A. Reiprich, L. Skalden, A. Raab, N. Bolotina, C. Lang. Lactobacillus crispatus DSM25988 as novel bioactive agent to co-aggregate Streptococcus pyogenes and to exclude it by binding to human cells. Beneficial Microbes 2022; 13(1): 83 doi: 10.3920/BM2021.0103
|
| 31 |
Ángel Gabriel Salinas Ibáñez, Anabella L. Origone, Constanza S. Liggieri, Sonia E. Barberis, Alba E. Vega. Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.961958
|
| 32 |
Doaa M. Al-Eraky, Omneya M. Helmy, Yasser M. Ragab, Zeinab Abdul-Khalek, Eman A. El-Seidi, Mohammed A. Ramadan. Prevalence of CagA and antimicrobial sensitivity of H. pylori isolates of patients with gastric cancer in Egypt. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0198-1
|
| 33 |
Yongfu Shao, Yifan Lin, Ziyi Fang, Jianing Yan, Tuo Zheng, Guoliang Ye. Analysis of Helicobacter pylori resistance in patients with different gastric diseases. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55589-2
|
| 34 |
Farkhondeh Poursina, Jamshid Fagri, Nasrin Mirzaei, Hajieh Ghasemian Safaei. Overexpression of spoT gene in coccoid forms of clinical Helicobacter pylori isolates. Folia Microbiologica 2018; 63(4): 459 doi: 10.1007/s12223-017-0557-0
|
| 35 |
Bahgat Fayed, Jayalakshmi Jagal, Roberta Cagliani, Reena A. Kedia, Amr Elsherbeny, Hulya Bayraktutan, Ghalia Khoder, Mohamed Haider. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment. International Journal of Biological Macromolecules 2023; 253: 126706 doi: 10.1016/j.ijbiomac.2023.126706
|
| 36 |
Ali Sadra, Hyuck-Se Kweon, Sung-Oh Huh, Jaeyoung Cho. Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extract. Animal Cells and Systems 2017; 21(4): 255 doi: 10.1080/19768354.2017.1357660
|
| 37 |
Qian Zhao, Wen-jia Wang, Shui-ping Zhou, Jing Su, He Sun, Jing-bo Zhai, Yun-hui Hu. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.959184
|
| 38 |
Sumaira Khadim, Iyad Muhammad Naeem, Muhammad Tanveer Alam, Hina Rehman, Sidra Ghayas, Sajjad Haider. The efficacy of moxifloxacin-based triple-therapy in first-line treatment of Helicobacter pylori infection in Pakistan: randomized controlled trials. Archives of Medical Science – Civilization Diseases 2023; 8(1): 31 doi: 10.5114/amscd.2023.131926
|
| 39 |
Sho Suzuki, Takuji Gotoda, Chika Kusano, Kunio Iwatsuka, Mitsuhiko Moriyama. The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. American Journal of Gastroenterology 2016; 111(7): 949 doi: 10.1038/ajg.2016.182
|
| 40 |
Logan T. Roberts, Peter P. Issa, Evan S. Sinnathamby, Mallory Granier, Holly Mayeux, Treniece N. Eubanks, Kevin Malone, Shahab Ahmadzadeh, Elyse M. Cornett, Sahar Shekoohi, Alan D. Kaye. Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice. Life 2022; 12(12): 2038 doi: 10.3390/life12122038
|
| 41 |
Amirarsalan Serajian. PCR-RFLP Detection of Point Mutations in 23sr RNA Gene Responsible for Clarithromycin Resistance in Helicobacter pylori Isolates of Ahvaz, Iran. International Journal of Molecular Biology 2017; 2(5) doi: 10.15406/ijmboa.2017.02.00038
|
| 42 |
Su Young Kim, Jun-Won Chung. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics 2020; 9(8): 436 doi: 10.3390/antibiotics9080436
|
| 43 |
Ángel Gabriel Salinas Ibáñez, Diego Vallés, Mauricio Adaro, Sonia Barberis, Alba E. Vega. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.699955
|
| 44 |
Axel Haverich, Erin Colleen Boyle. Atherosklerose-Pathogenese und mikrovaskuläre Dysfunktion. 2023; : 9 doi: 10.1007/978-3-031-31766-8_2
|
| 45 |
Asghar Ali, Khalid I. AlHussaini. Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies. Microorganisms 2024; 12(1): 222 doi: 10.3390/microorganisms12010222
|
| 46 |
David R. Scott, George Sachs, Elizabeth A. Marcus. The role of acid inhibition in Helicobacter pylori eradication. F1000Research 2016; 5: 1747 doi: 10.12688/f1000research.8598.1
|
| 47 |
Ashutosh Gupta, Prerana D. Navti, Srinivas Mutalik, Moumita Saha, Sudheer Moorkoth. DoE Guided Development of an HPLC Method for Evaluation of Amoxicillin and Metronidazole Co-loaded Mucoadhesive GRDDS Formulation for H. pylori Eradication. Chromatographia 2023; 86(11-12): 729 doi: 10.1007/s10337-023-04290-z
|
| 48 |
Abhigan Babu Shrestha, Pashupati Pokharel, Unnat Hamal Sapkota, Sajina Shrestha, Shueb A. Mohamed, Surakshya Khanal, Saroj Kumar Jha, Aroop Mohanty, Bijaya Kumar Padhi, Ankush Asija, Yub Raj Sedhai, Rishikesh Rijal, Karan Singh, Vijay Kumar Chattu, Alfonso J. Rodriguez-Morales, Joshuan J. Barboza, Ranjit Sah. Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Helicobacter pylori Infection among South Asian Countries: A Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease 2023; 8(3): 172 doi: 10.3390/tropicalmed8030172
|
| 49 |
Patrícia C. Henriques, Lia M. Costa, Catarina L. Seabra, Bernardo Antunes, Ricardo Silva-Carvalho, Susana Junqueira-Neto, André F. Maia, Pedro Oliveira, Ana Magalhães, Celso A. Reis, Fátima Gartner, Eliette Touati, Joana Gomes, Paulo Costa, M. Cristina L. Martins, Inês C. Gonçalves. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice. Acta Biomaterialia 2020; 114: 206 doi: 10.1016/j.actbio.2020.06.035
|
| 50 |
Hiroshi Matsumoto, Akiko Shiotani, Ryo Katsumata, Minoru Fujita, Rui Nakato, Takahisa Murao, Manabu Ishii, Tomoari Kamada, Ken Haruma, David Y. Graham. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Digestive Diseases and Sciences 2016; 61(11): 3215 doi: 10.1007/s10620-016-4305-0
|
| 51 |
Shoko Ono, Mototsugu Kato, Soichi Nakagawa, Katsuhiro Mabe, Naoya Sakamoto. Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin. Helicobacter 2017; 22(3) doi: 10.1111/hel.12374
|
| 52 |
Kalyani Saha, Deotima Sarkar, Uzma Khan, Bipul Chandra Karmakar, Sangita Paul, Asish K. Mukhopadhyay, Shanta Dutta, Sushmita Bhattacharya. Capsaicin Inhibits Inflammation and Gastric Damage during H pylori Infection by Targeting NF-kB–miRNA Axis. Pathogens 2022; 11(6): 641 doi: 10.3390/pathogens11060641
|
| 53 |
Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo, Dong Kyun Park. Tailored eradication strategy <i>vs</i> concomitant therapy for <i>Helicobacter pylori</i> eradication treatment in Korean patients. World Journal of Gastroenterology 2021; 27(31): 5247-5258 doi: 10.3748/wjg.v27.i31.5247
|
| 54 |
Paolo Governa, Giulia Romagnoli, Paola Albanese, Federico Rossi, Fabrizio Manetti, Marco Biagi.
Effect of
in vitro
simulated digestion on the anti-
Helicobacter Pylori
activity of different Propolis extracts
. Journal of Enzyme Inhibition and Medicinal Chemistry 2023; 38(1) doi: 10.1080/14756366.2023.2183810
|
| 55 |
Andrzej Czyrski. Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A Review. Chromatographia 2017; 80(2): 181 doi: 10.1007/s10337-016-3224-8
|
| 56 |
Vanita Mulay, Dhanashri Satav, Austin Fernandez, Priyanka Pisalwar, Shadab Ahmed. Alternatives to Antibiotics. 2022; : 499 doi: 10.1007/978-981-19-1854-4_20
|
| 57 |
Tuncer Ozturk, Demet Sengul, Ilker Sengul. Helicobacter pyloriand association between its positivity and anatomotopographic settlement in the stomach with the host age range. Annals of African Medicine 2021; 20(1): 1 doi: 10.4103/aam.aam_69_19
|
| 58 |
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
|
| 59 |
Steffanie S. Amadei, Vicente Notario. A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives. Antibiotics 2020; 9(9): 580 doi: 10.3390/antibiotics9090580
|
| 60 |
Manuel Palencia, Tulio A. Lerma, Viviana Garcés, Mayra A. Mora, Jina M. Martínez, Sixta L. Palencia. Eco-friendly Functional Polymers. 2021; : 433 doi: 10.1016/B978-0-12-821842-6.00006-3
|
| 61 |
Daphne Ang, Seok Hwee Koo, Yiong Huak Chan, Thean Yen Tan, Gaik Hong Soon, Chin Kimg Tan, Kenneth Weicong Lin, Jaydeesh‐Khanna Krishnasamy‐Balasubramanian, Yu Jun Wong, Rahul Kumar, Rajesh R, Yiyuan Tan, Peng‐Lan Jeannie Ong, Yi‐Lyn Jessica Tan, James Weiquan Li, Andrew Boon‐Eu Kwek, Tiing Leong Ang. Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2022; 56(3): 436 doi: 10.1111/apt.17070
|
| 62 |
Mahdi Tarhini, Mohammad Fayyad-Kazan, Hussein Fayyad-Kazan, Mahmoud Mokbel, Mohammad Nasreddine, Bassam Badran, Ghada Kchour. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. Microbial Pathogenesis 2018; 117: 23 doi: 10.1016/j.micpath.2018.02.010
|
| 63 |
Carla Palacios-Gorba, Raquel Pina, Miguel Tortajada-Girbés, Ana Jiménez-Belenguer, Érica Siguemoto, Maria Antonia Ferrús, Dolores Rodrigo, Maria Consuelo Pina-Pérez. Caenorhabditis elegans as an in vivo model to assess fucoidan bioactivity preventing Helicobacter pylori infection. Food & Function 2020; 11(5): 4525 doi: 10.1039/D0FO00768D
|
| 64 |
Huili Shen, Yijie Chen, Xiaohui Li, Jing Yan, Junjie Zhao, Demin Kong, Yanxia Shi, Zhihui Li, Jihong Wang, Na Shao, Zhenghui Wang, Xueliang Wu. Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/8266321
|